LC Sciences' products and services are based on developed parallel-synthesis and targeted sequencing technologies.
LC Sciences' µParaflo microfluidic on-chip synthesis technology enables customizable arrays of oligonucleotides, peptides, and their analog molecules. Their line of microarray services includes microRNA profiling, custom oligonucleotide (aptamer) screening, and peptide arrays for epitope mapping, protein kinase substrate profiling, and phosphopeptide binding assays.
LC's OligoMix technology is used for genome-scale experiments such as exploration of small RNAs and designer gene/DNA library synthesis. OligoMix technology has been applied to library construction of various biomolecules, sequence capture for targeted next-gen sequencing, and synthetic biology.
LC Sciences has developed the underlying technologies for a targeted sequencing system engineered to accomplish accurate NGS testing (target selection, library preparation and molecular tagging).
LC Sciences has patents pending for Relay-PCRTM and Omega-PrimerTM technologies which are used in their VariantPro targeted sequencing system.